Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 61/73 ]
NASDAQ | Common Stock
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices.
Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain.
The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies.
NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
May 13, 25 | -0.87 Increased by +19.76% | - |
Oct 24, 24 | -0.75 Decreased by -259.06% | - |
Aug 6, 24 | -0.74 Decreased by -281.43% | - |
May 15, 24 | -1.67 Decreased by -735.75% | - |
Feb 22, 24 | -1.08 Decreased by -1.10 K% | - |
Oct 26, 23 | -0.21 Increased by +9.74% | - |
Jul 27, 23 | -0.19 Decreased by -14.65% | - |
May 3, 23 | -0.20 Increased by +82.14% | - |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Mar 31, 25 | 582.82 K Decreased by -46.70% | -1.78 M Increased by +41.24% | Decreased by -305.47% Decreased by -10.26% |
Dec 31, 24 | 582.82 K Decreased by -55.77% | -1.78 M Decreased by -7.93% | Decreased by -305.47% Decreased by -144.02% |
Sep 30, 24 | 587.31 K Decreased by -51.19% | -1.51 M Increased by +14.73% | Decreased by -256.80% Decreased by -74.69% |
Jun 30, 24 | 769.15 K Decreased by -53.55% | -1.49 M Increased by +3.19% | Decreased by -193.45% Decreased by -108.39% |
Mar 31, 24 | 1.09 M Decreased by -36.60% | -3.03 M Decreased by -110.64% | Decreased by -277.04% Decreased by -232.22% |
Dec 31, 23 | 1.32 M Decreased by -28.67% | -1.65 M Decreased by -141.99% | Decreased by -125.18% Decreased by -239.26% |
Sep 30, 23 | 1.20 M Decreased by -38.86% | -1.77 M Decreased by -17.95% | Decreased by -147.01% Decreased by -92.94% |
Jun 30, 23 | 1.66 M Decreased by -22.57% | -1.54 M Decreased by -38.53% | Decreased by -92.83% Decreased by -78.90% |